Roflumilast topical

Alternative Names: Zoryve

Topical roflumilast is a PDE4 inhibitor approved for treating mild-to-moderate eczema (atopic dermatitis). It works by reducing inflammation in the skin and offers a non-steroidal alternative to traditional treatments. Clinical trials have shown that once-daily use significantly improves symptoms like itching and redness in both children and adults, with good tolerability and few side effects

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the review by Dr. Curbside, Roflumilast topical appears to be a promising non-steroidal treatment for mild-to-moderate eczema. It offers an alternative to traditional topical corticosteroids and calcineurin inhibitors, particularly for patients who need long-term topical control or experience steroid side effects. The review suggests it can be a useful adjunct or alternative in eczema management.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
2.0
1 = Very Expensive 5 = Very Affordable

2.0

Expensive
Relief Speed
3.0
1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief
Side Effects
5.0
1 = Intolerable Effect 5 = No Effect

5.0

No Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review by Dr. Curbside, Roflumilast topical appears to be a promising non-steroidal treatment for mild-to-moderate eczema. It offers an alternative to traditional topical corticosteroids and calcineurin inhibitors, particularly for patients who need long-term topical control or experience steroid side effects. The review suggests it can be a useful adjunct or alternative in eczema management.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Topical roflumilast is a non-steroidal medication used to treat mild-to-moderate eczema. It works as a PDE4 inhibitor and can be a good option for patients who want to avoid steroids or who have had side effects from them. I often think of it as an alternative to topical steroids or calcineurin inhibitors for longer-term control. It can also be used along with systemic biologics as another topical therapy when needed, including when documenting adequate topical treatment for insurance approval. One downside is that it can be quite expensive depending on insurance coverage.
#Expensive #CoveredByInsurance #ModerateRelief #NoEffect #Second-line #Maintenance